Literature DB >> 190881

Conversion of angiotensin I to angiotensin II.

E G Erdös.   

Abstract

The angiotensin I converting enzyme has two important functions: it inactivates bradykinin and converts angiotensin I to angiotensin II. Inhibition of the enzyme blocks the renin-angiotensin system and decreases systemic blood pressure if the pressure is maintained or increased by renin. The enzyme occurs in a variety of tissues and cell forms. The vascular endothelial cells of the lung and of peripheral blood vessels, and the epithelial cells of the kidney tubules are major sources of the enzyme. In addition to inactivating hypotensive peptides and activating a hypertensive one in the systemic circulation, the enzyme may affect organ functions by hydrolyzing peptides that are formed and released locally.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 190881     DOI: 10.1016/0002-9343(76)90889-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  42 in total

1.  Association study of ACE polymorphisms and systemic lupus erythematosus in Northern Chinese Han population.

Authors:  Ai-Min Gong; Xin-Yuan Li; Yi-Qin Wang; Hai-Xia Yan; Zhao-Xia Xu; Zhao Feng; Yi-Qiang Xie; De-Hui Yin; Shi-Zhong Yang
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

2.  Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude.

Authors:  Yue Qi; Wenquan Niu; Tongchun Zhu; Wenyu Zhou; Changchun Qiu
Journal:  Eur J Epidemiol       Date:  2007-11-07       Impact factor: 8.082

3.  Effect of the inhibitor of angiotensin I converting enzyme on endocrine function and renal perfusion in haemorrhagic shock.

Authors:  M Yamashita; T Oyama; T Kudo
Journal:  Can Anaesth Soc J       Date:  1977-11

Review 4.  Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?

Authors:  R Komers; S Anderson
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

5.  Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation.

Authors:  M Majima; K Nishiyama; Y Iguchi; K Yao; M Ogino; T Ohno; N Sunahara; K Katoh; N Tatemichi; Y Takei; M Katori
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

6.  Uptake of 125I-labelled C3a by cultured human endothelial cells.

Authors:  J B Denney; A R Johnson
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

7.  Maternal nutrient restriction in sheep: hypertension and decreased nephron number in offspring at 9 months of age.

Authors:  Jeffrey S Gilbert; Alvin L Lang; Angela R Grant; Mark J Nijland
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

8.  Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.

Authors:  S Rich; J Martinez; W Lam; K M Rosen
Journal:  Br Heart J       Date:  1982-09

9.  Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.

Authors:  A R Johnson; E G Erdös
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

10.  The role of kininogenases, kinin formation and kininogenase inhibition in post traumatic shock and related conditions.

Authors:  G L Haberland
Journal:  Klin Wochenschr       Date:  1978-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.